GSC
GILD icon

G&S Capital’s Gilead Sciences GILD Stock Holding History

G&S Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,876
Closed -$2.81M – 138
2025
Q4 		$2.81M Sell
22,876
-613
-3% -$74.5K 0.99% 38
2025
Q3 		$2.61M Buy
23,489
+164
+0.7% +$18.6K 0.96% 39
2025
Q2 		$2.59M Buy
+23,325
New +$2.48M 1.02% 36
2020
Q2 		– Sell
-12,472
Closed -$932K – 114
2020
Q1 		$932K Buy
+12,472
New +$862K 1.63% 14

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

G&S Capital's GILD Position: Q1 2026 in Review

G&S Capital sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 22,876 shares — an estimated $2.81M sold.

G&S Capital first reported a position in GILD in Q1 2020 and held it in 4 quarters. The position peaked at $2.81M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • G&S Capital reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • G&S Capital sold 22,876 Gilead Sciences shares in Q1 2026, an estimated $2.81M.
  • G&S Capital first reported a position in Gilead Sciences in Q1 2020 and held it in 4 quarters.
  • G&S Capital's Gilead Sciences position peaked at $2.81M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on G&S Capital's 13F filing for Q1 2026, filed 7 Apr 2026.